Learn More
BioVendor, LLC Fgf-23 Human Elisa BioVendor LLC

Supplier: BioVendor, LLC RBL007R
Fibroblast growth factor-23 (FGF-23) is a phosphaturic hormone involved in mineral bone metabolism that helps control phosphate homeostasis and reduces 1,25- dihydroxyvitamin D synthesis. Recent data have highlighted the relevant direct FGF-23 effects on the myocardium, and high plasma levels of FGF-23 have been associated with adverse cardiovascular outcomes in humans, such as heart failure and arrhythmias. Therefore, FGF-23 has emerged as a novel biomarker of cardiovascular risk. experimental data suggest FGF-23 as a direct mediator of cardiac hypertrophy development, cardiac fibrosis and cardiac dysfunction via specific myocardial FGF receptor (FGFR) activation. One kit (96 wells). Type: sandwich ELISA. Sample type: Plasma (EDTA), urine. Sample requirement: 50 ¿l/well. Calibration range: 50-2000pg/ml. Limit of detection: 25pg/ml. Other names: Fibroblast Growth Factor 23, Phosphatonin, Tumor-derived hypophosphatemia-inducing factor, FGF23.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.